Publications by authors named "W Jungraithmayr"
Article Synopsis
- Remote organ dysfunction is common after lung transplantation and may negatively impact the patient’s outcome, prompting an investigation into protective measures.
- A study on mice showed that lung transplantation increased specific molecular markers of injury in the kidneys and liver, indicating a response to the transplant.
- Ropivacaine, while previously shown to reduce acute rejection in lung transplants, did not significantly affect inflammation markers in the remote organs during this study.
Background: Lung transplantation (LTx) remains the only efficient treatment for selected patients with end-stage pulmonary disease. The age limit for the acceptance of donor organs in LTx is still a matter of debate. We here analyze the impact of donor organ age and the underlying pulmonary disease on short- and long-term outcome and survival after LTx.
View Article and Find Full Text PDFCurrently, lung transplantation outcome remains inferior compared to other solid organ transplantations. A major cause for limited survival after lung transplantation is chronic lung allograft dysfunction. Numerous animal models have been developed to investigate chronic lung allograft dysfunction to discover adequate treatments.
View Article and Find Full Text PDFBackground: Organ selection in lung transplantation (LTx) is still controversial. We here analyze the impact of mismatches in size, age, and gender on early and long-term outcome after LTx.
Methods: Retrospective analysis of donor and recipient characteristics of patients who underwent double LTx between March 2003 and December 2021.